These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 31381497)

  • 21. Oral administration of HPV-16 L2 displayed on Lactobacillus casei induces systematic and mucosal cross-neutralizing effects in Balb/c mice.
    Yoon SW; Lee TY; Kim SJ; Lee IH; Sung MH; Park JS; Poo H
    Vaccine; 2012 May; 30(22):3286-94. PubMed ID: 22426329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccination of healthy volunteers with human papillomavirus type 16 L2E7E6 fusion protein induces serum antibody that neutralizes across papillomavirus species.
    Gambhira R; Gravitt PE; Bossis I; Stern PL; Viscidi RP; Roden RB
    Cancer Res; 2006 Dec; 66(23):11120-4. PubMed ID: 17145854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenicity of an HPV-16 L2 DNA vaccine.
    Hitzeroth II; Passmore JA; Shephard E; Stewart D; Müller M; Williamson AL; Rybicki EP; Kast WM
    Vaccine; 2009 Oct; 27(46):6432-4. PubMed ID: 19559114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HPV16 L1 capsid protein expressed from viable adenovirus recombinants elicits neutralizing antibody in mice.
    Berg M; Gambhira R; Siracusa M; Hoiczyk E; Roden R; Ketner G
    Vaccine; 2007 Apr; 25(17):3501-10. PubMed ID: 16914239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Displaying 31RG-1 peptide on the surface of HPV16 L1 by use of a human papillomavirus chimeric virus-like particle induces cross-neutralizing antibody responses in mice.
    Chen X; Zhang T; Liu H; Hao Y; Liao G; Xu X
    Hum Vaccin Immunother; 2018; 14(8):2025-2033. PubMed ID: 29683766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purification and immunogenicity study of human papillomavirus type 16 L1 protein in Saccharomyces cerevisiae.
    Kim SN; Jeong HS; Park SN; Kim HJ
    J Virol Methods; 2007 Jan; 139(1):24-30. PubMed ID: 17034867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A human papillomavirus (HPV) in vitro neutralization assay that recapitulates the in vitro process of infection provides a sensitive measure of HPV L2 infection-inhibiting antibodies.
    Day PM; Pang YY; Kines RC; Thompson CD; Lowy DR; Schiller JT
    Clin Vaccine Immunol; 2012 Jul; 19(7):1075-82. PubMed ID: 22593236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preclinical refinements of a broadly protective VLP-based HPV vaccine targeting the minor capsid protein, L2.
    Tumban E; Muttil P; Escobar CA; Peabody J; Wafula D; Peabody DS; Chackerian B
    Vaccine; 2015 Jun; 33(29):3346-53. PubMed ID: 26003490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Preparation and activity detection of chicken egg yolk IgY antibody against human papillomavirus 16 type L1 main capsid protein].
    Yang J; Zhang MJ; Qiang L; Su BS; Wang YL; Si LS
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):324-7. PubMed ID: 18359682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rectal and vaginal immunization of mice with human papillomavirus L1 virus-like particles.
    Fraillery D; Zosso N; Nardelli-Haefliger D
    Vaccine; 2009 Apr; 27(17):2326-34. PubMed ID: 19428847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intranasal vaccination with AAV5 and 9 vectors against human papillomavirus type 16 in rhesus macaques.
    Nieto K; Stahl-Hennig C; Leuchs B; Müller M; Gissmann L; Kleinschmidt JA
    Hum Gene Ther; 2012 Jul; 23(7):733-41. PubMed ID: 22401308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Construction and immunological evaluation of recombinant adenovirus containing codon-modified HPV 16 L1 gene].
    Zhou YB; Zhou L; Li ZL; Sheng W; Zeng Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Feb; 22(1):18-20. PubMed ID: 18414690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined prophylactic and therapeutic intranasal vaccination against human papillomavirus type-16 using different adeno-associated virus serotype vectors.
    Nieto K; Kern A; Leuchs B; Gissmann L; Müller M; Kleinschmidt JA
    Antivir Ther; 2009; 14(8):1125-37. PubMed ID: 20032542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of mucosal and systemic immune responses following oral immunization of mice with Lactococcus lactis expressing human papillomavirus type 16 L1.
    Cho HJ; Shin HJ; Han IK; Jung WW; Kim YB; Sul D; Oh YK
    Vaccine; 2007 Nov; 25(47):8049-57. PubMed ID: 17936447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral immunization with different assembly forms of the HPV 16 major capsid protein L1 induces neutralizing antibodies and cytotoxic T-lymphocytes.
    Thönes N; Müller M
    Virology; 2007 Dec; 369(2):375-88. PubMed ID: 17822733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Minor Capsid Protein L2 Polytope Induces Broad Protection against Oncogenic and Mucosal Human Papillomaviruses.
    Pouyanfard S; Spagnoli G; Bulli L; Balz K; Yang F; Odenwald C; Seitz H; Mariz FC; Bolchi A; Ottonello S; Müller M
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29212932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a novel viral DNA vaccine against human papillomavirus: AcHERV-HP16L1.
    Lee HJ; Park N; Cho HJ; Yoon JK; Van ND; Oh YK; Kim YB
    Vaccine; 2010 Feb; 28(6):1613-9. PubMed ID: 19961961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipidated L2 epitope repeats fused with a single-chain antibody fragment targeting human FcγRI elicited cross-neutralizing antibodies against a broad spectrum of human papillomavirus types.
    Zhang T; Liu H; Chen X; Wang Z; Wang S; Qu C; Zhang J; Xu X
    Vaccine; 2016 Nov; 34(46):5531-5539. PubMed ID: 27729176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunization with Human Papillomavirus 16 L1+E2 Chimeric Capsomers Elicits Cellular Immune Response and Antitumor Activity in a Mouse Model.
    López-Toledo G; Schädlich L; Alonso-Castro ÁJ; Monroy-García A; García-Rocha R; Guido MC; Gissmann L; García-Carrancá A
    Viral Immunol; 2016 Jun; 29(5):276-87. PubMed ID: 27058179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of vaccine delivery system on the induction of HPV16L1-specific humoral and cell-mediated immune responses in immunized rhesus macaques.
    Tobery TW; Smith JF; Kuklin N; Skulsky D; Ackerson C; Huang L; Chen L; Cook JC; McClements WL; Jansen KU
    Vaccine; 2003 Mar; 21(13-14):1539-47. PubMed ID: 12615451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.